Derm-Biome Pharmaceuticals, Inc. is a preclinical biopharmaceutical company with a suite of small molecule, natural product-based derivatives that show significant promise to become future standards of care for chronic inflammatory skin diseases with significant unmet need, such as eczema (atopic dermatitis) and acne, and for precancerous skin disorders and skin cancer (squamous cell carcinoma).